These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation. Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476 [TBL] [Abstract][Full Text] [Related]
34. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation. Auerbach SR; Manlhiot C; Reddy S; Kinnear C; Richmond ME; Gruber D; McCrindle BW; Deng L; Chen JM; Addonizio LJ; Chung WK; Mital S J Am Coll Cardiol; 2009 May; 53(20):1909-17. PubMed ID: 19442892 [TBL] [Abstract][Full Text] [Related]
35. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database. Weiss ES; Nwakanma LU; Patel ND; Yuh DD J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225 [TBL] [Abstract][Full Text] [Related]
36. C4d-the witness of humoral rejection. de Gouveia RH; Vitorino E; Ramos S; Rebocho MJ; Queirós E Melo J; Martins AP; Moura ML Transplant Proc; 2009 Apr; 41(3):866-7. PubMed ID: 19376374 [TBL] [Abstract][Full Text] [Related]
37. A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation. Kfoury AG; Renlund DG; Snow GL; Stehlik J; Folsom JW; Fisher PW; Reid BB; Clayson SE; Gilbert EM; Everitt MD; Bader FM; Singhal AK; Hammond ME J Heart Lung Transplant; 2009 Jan; 28(1):51-7. PubMed ID: 19134531 [TBL] [Abstract][Full Text] [Related]
38. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant. Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302 [TBL] [Abstract][Full Text] [Related]
39. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy. Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667 [TBL] [Abstract][Full Text] [Related]
40. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P; Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]